WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005037294) COMPOSITIONS FOR CONTROLLING PARASITES COMPRISING A COMBINATION OF ABAMECTIN AND IVERMECTIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/037294    International Application No.:    PCT/EP2004/052554
Publication Date: 28.04.2005 International Filing Date: 15.10.2004
IPC:
A61K 31/7048 (2006.01), A61K 47/44 (2006.01)
Applicants: AKZO NOBEL N.V. [NL/NL]; Velperweg 76, NL-6824 BM Arnhem (NL) (For All Designated States Except US).
CHO, Hyun, Sun [KR/BR]; (BR) (For US Only).
SANTOS, Edival, Junior [BR/BR]; (BR) (For US Only).
DA COSTA, Alvimar Jose [BR/BR]; (BR) (For US Only)
Inventors: CHO, Hyun, Sun; (BR).
SANTOS, Edival, Junior; (BR).
DA COSTA, Alvimar Jose; (BR)
Agent: STUMM, K.; Intervet International B.V., P.O. Box 31, NL-5830 AA Boxmeer (NL)
Priority Data:
03078280.9 17.10.2003 EP
Title (EN) COMPOSITIONS FOR CONTROLLING PARASITES COMPRISING A COMBINATION OF ABAMECTIN AND IVERMECTIN
(FR) COMPOSITIONS A EFFET PROLONGE COMPRENANT UNE COMBINAISON D'AVERMECTINES
Abstract: front page image
(EN)A long acting composition for controlling parasites in and on animals, which comprises in a slow release vehicle a combination of ivermectin and abamectin, wherein the total percentage w/v of ivermectin and abamectin equals or exceeds 3% w/v and the concentration of ivermectin is higher than the concentration of abamectin.
(FR)La présente invention concerne une composition à effet prolongé destinée à éliminer les parasites internes et externes chez l'animal, cette composition comprenant dans un vecteur à libération lente, une combinaison d'ivermectine et d'abamectine telle que le pourcentage total en poids/volume d'ivermectine et d'abamectine soit égal ou supérieur à 3 % en poids/volume et que la concentration d'ivermectine soit supérieure à la concentration d'abamectine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)